| 45.62 Delayed Data As of 4:00pm ET |  -0.43 / -0.93%Today’s Change | 40.00 Today|||52-Week Range 47.47 | +5.09% Year-to-Date |
| 2 Biotech Stocks Fighting Alzheimer’s Disease to Own Now Nov 09 / MotleyFool.com - Paid Partner Content | Sanofi (SNY) Q3 2019 Earnings Call Transcript Nov 01 / MotleyFool.com - Paid Partner Content |
| Could Novavax Be a Millionaire-Maker Stock? Nov 02 / MotleyFool.com - Paid Partner Content |
| Previous close | 46.05 |
| Today’s open | 45.90 |
| Day’s range | 45.53 - 45.94 |
| Volume | 933,645 |
| Average volume (3 months) | 1,444,350 |
| Market cap | $114.3B |
| Earnings growth (last year) | +19.94% |
| Earnings growth (this year) | +5.23% |
| Earnings growth (next 5 years) | +7.00% |
| Revenue growth (last year) | +2.83% |
| P/E ratio | 29.0 |
| Price/Sales | 2.68 |
| Price/Book | 1.70 |
| Today’s change | Today’s % change | |
|---|---|---|
| GSKGlaxoSmithKline | +0.14 | +0.31% |
| LLYEli Lilly and Co | -0.38 | -0.34% |
| AZNAstraZeneca | +0.74 | +1.57% |
| NVONovo Nordisk | +0.55 | +0.96% |
| Next reporting date | February 6, 2020 |
| EPS forecast (this quarter) | $0.70 |
| Annual revenue (last year) | $40.7B |
| Annual profit (last year) | $5.1B |
| Net profit margin | 12.53% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Paris, Ile-de-france |
